{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T17:26:44Z","timestamp":1774114004031,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"P.E. Kempkes Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12987-017-0070-5","type":"journal-article","created":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T07:59:03Z","timestamp":1502697543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Profiling of metalloprotease activities in cerebrospinal fluids of patients with neoplastic meningitis"],"prefix":"10.1186","volume":"14","author":[{"given":"Catharina","family":"Conrad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Dorzweiler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miles A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas A.","family":"Lauffenburger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herwig","family":"Strik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg W.","family":"Bartsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,14]]},"reference":[{"key":"70_CR1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1474-4422(06)70443-4","volume":"5","author":"B Gleissner","year":"2006","unstructured":"Gleissner B, Chamberlain MC. Neoplastic meningitis. Lancet Neurol. 2006;5:443\u201352.","journal-title":"Lancet Neurol"},{"key":"70_CR2","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1586\/era.10.86","volume":"10","author":"H Strik","year":"2010","unstructured":"Strik H, Pr\u00f6mmel P. Diagnosis and individualized therapy of neoplastic meningitis. Expert Rev Anticancer Ther. 2010;10:1137\u201348.","journal-title":"Expert Rev Anticancer Ther"},{"key":"70_CR3","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.seminoncol.2009.05.005","volume":"36","author":"MC Chamberlain","year":"2009","unstructured":"Chamberlain MC, Glantz M, Groves MD, Wilson WH. Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment. Semin Oncol. 2009;36:S35\u201345.","journal-title":"Semin Oncol"},{"key":"70_CR4","doi-asserted-by":"crossref","first-page":"248072","DOI":"10.1155\/2013\/248072","volume":"2013","author":"P Pr\u00f6mmel","year":"2013","unstructured":"Pr\u00f6mmel P, Pilgram-Pastor S, Sitter H, Buhk JH, Strik H. Neoplastic meningitis: How MRI and CSF cytology are influenced by CSF cell count and tumor type. Sci World J. 2013;2013:248072.","journal-title":"Sci World J"},{"key":"70_CR5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/ctrv.1999.0119","volume":"25","author":"SA Grossman","year":"1999","unstructured":"Grossman SA, Krabak MJ. Leptomeningeal carcinomatosis. Cancer Treat Rev. 1999;25:103\u201319.","journal-title":"Cancer Treat Rev"},{"key":"70_CR6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1081\/CNV-50458","volume":"23","author":"LM DeAngelis","year":"2005","unstructured":"DeAngelis LM, Boutros D. Leptomeningeal metastasis. Cancer Invest. 2005;23:145\u201354.","journal-title":"Cancer Invest"},{"key":"70_CR7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2045-8118-8-14","volume":"8","author":"CL Weston","year":"2011","unstructured":"Weston CL, Glantz MJ, Connor JR. Detection of cancer cells in the cerebrospinal fluid: current methods and future directions. Fluids Barriers CNS. 2011;8:14.","journal-title":"Fluids Barriers CNS"},{"key":"70_CR8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11060-009-9819-2","volume":"94","author":"MD Groves","year":"2009","unstructured":"Groves MD, Hess KR, Puduvalli VK, Colman H, Conrad CA, Gilbert MR, Weinberg J, Cristofanilli M, Yung WK, Liu TJ. Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma. J Neurooncol. 2009;94:229\u201334.","journal-title":"J Neurooncol"},{"key":"70_CR9","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/blood-2004-05-1982","volume":"105","author":"U Hegde","year":"2005","unstructured":"Hegde U, Filie A, Little RF, Janik JE, Grant N, Steinberg SM, Dunleavy K, Jaffe ES, Abati A, Stetler-Stevenson M, Wilson WH. High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology. Blood. 2005;105:496\u2013502.","journal-title":"Blood"},{"key":"70_CR10","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1212\/01.wnl.0000261909.28915.83","volume":"68","author":"JE Bromberg","year":"2007","unstructured":"Bromberg JE, Breems DA, Kraan J, Bikker G, van der Holt B, Smitt PS, van den Bent MJ, van\u2019t Veer M, Gratama JW. CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies. Neurology. 2007;68:1674\u20139.","journal-title":"Neurology"},{"key":"70_CR11","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/pmic.200600719","volume":"7","author":"A R\u00f6mpp","year":"2007","unstructured":"R\u00f6mpp A, Dekker L, Taban I, Jenster G, Boogerd W, Bonfrer H, Spengler B, Heeren R, Smitt PS, Luider TM. Identification of leptomeningeal metastasis-related proteins in cerebrospinal fluid of patients with breast cancer by a combination of MALDI-TOF, MALDI-FTICR and nanoLC-FTICR MS. Proteomics. 2007;7:474\u201381.","journal-title":"Proteomics"},{"key":"70_CR12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.2007.12.1053","volume":"26","author":"S Roy","year":"2008","unstructured":"Roy S, Josephson SA, Fridlyand J, Karch J, Kadoch C, Karrim J, Damon L, Treseler P, Kunwar S, Shuman MA, Jones T, Becker CH, Schulman H, Rubenstein JL. Protein biomarker identification in the CSF of patients with CNS lymphoma. J Clin Oncol. 2008;26:96\u2013105.","journal-title":"J Clin Oncol"},{"key":"70_CR13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1039\/C0IB00083C","volume":"3","author":"MA Miller","year":"2011","unstructured":"Miller MA, Barkal L, Jeng K, Herrlich A, Moss M, Griffith LG, Lauffenburger DA. Proteolytic Activity Matrix Analysis (PrAMA) for simultaneous determination of multiple protease activities. Integr Biol. 2011;3:422\u201338.","journal-title":"Integr Biol"},{"key":"70_CR14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1349-7006.2007.00434.x","volume":"98","author":"S Mochizuki","year":"2007","unstructured":"Mochizuki S, Okada Y. ADAMs in cancer cell proliferation and progression. Cancer Sci. 2007;98:621\u20138.","journal-title":"Cancer Sci"},{"key":"70_CR15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141:52\u201367.","journal-title":"Cell"},{"key":"70_CR16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.tcb.2010.12.002","volume":"21","author":"SD Mason","year":"2011","unstructured":"Mason SD, Joyce JA. Proteolytic networks in cancer. Trends Cell Biol. 2011;21:228\u201337.","journal-title":"Trends Cell Biol"},{"key":"70_CR17","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1212\/NXI.0000000000000246","volume":"3","author":"D Jones","year":"2016","unstructured":"Jones D, Alvarez E, Selva S, Gilden D, Nagel MA. Proinflammatory cytokines and matrix metalloproteinases in CSF of patients with VZV vasculopathy. Neurol Neuroimmunol Neuroinflamm. 2016;3:e246.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"70_CR18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00011-014-0786-5","volume":"64","author":"T Patil","year":"2015","unstructured":"Patil T, Garg RK, Jain A, Goel MM, Malhotra HS, Verma R, Singh GP, Sharma PK. Serum and CSF cytokines and matrix metalloproteinases in spinal tuberculosis. Inflamm Res. 2015;64:97\u2013106.","journal-title":"Inflamm Res"},{"key":"70_CR19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/514198","volume":"177","author":"G Perides","year":"1998","unstructured":"Perides G, Charness ME, Tanner LM, P\u00e9ter O, Satz N, Steere AC, Klempner MS. Matrix metalloproteinases in the cerebrospinal fluid of patients with Lyme neuroborreliosis. J Infect Dis. 1998;177:401\u20138.","journal-title":"J Infect Dis"},{"key":"70_CR20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0165-5728(97)00247-6","volume":"84","author":"SA Kolb","year":"1998","unstructured":"Kolb SA, Lahrtz F, Paul R, Leppert D, Nadal D, Pfister HW, Fontana A. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid. J Neuroimmunol. 1998;84:143\u201350.","journal-title":"J Neuroimmunol"},{"key":"70_CR21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1086\/313922","volume":"31","author":"D Leppert","year":"2000","unstructured":"Leppert D, Leib SL, Grygar C, Miller KM, Schaad UB, Holl\u00e4nder GA. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood\u2013brain barrier damage and neurological sequelae. Clin Infect Dis. 2000;31:80\u20134.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"70_CR22","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1177\/1352458516672015","volume":"23","author":"T Uchida","year":"2016","unstructured":"Uchida T, Mori M, Uzawa A, Masuda H, Muto M, Ohtani R, Kuwabara S. Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: their possible role on blood\u2013brain barrier disruption. Mult Scler J. 2016;23(8):1072\u201384.","journal-title":"Mult Scler J."},{"key":"70_CR23","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/glia.10226","volume":"42","author":"BC Kieseier","year":"2003","unstructured":"Kieseier BC, Pischel H, Neuen-Jacob E, Tourtellotte WW, Hartung HP. ADAM-10 and ADAM-17 in the inflamed human CNS. Glia. 2003;42:398\u2013405.","journal-title":"Glia"},{"issue":"Pt 12","key":"70_CR24","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1093\/brain\/121.12.2327","volume":"121","author":"D Leppert","year":"1998","unstructured":"Leppert D, Ford J, Stabler G, Grygar C, Lienert C, Huber S, Miller KM, Hauser SL, Kappos L. Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain. 1998;121(Pt 12):2327\u201334.","journal-title":"Brain"},{"key":"70_CR25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0165-5728(03)00006-7","volume":"136","author":"C Avolio","year":"2003","unstructured":"Avolio C, Ruggieri M, Giuliani F, Liuzzi GM, Leante R, Riccio P, Livrea P, Trojano M. Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes. J Neuroimmunol. 2003;136:46\u201353.","journal-title":"J Neuroimmunol"},{"key":"70_CR26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1742-2094-9-122","volume":"9","author":"M Light","year":"2012","unstructured":"Light M, Minor KH, DeWitt P, Jasper KH, Davies SJ. Multiplex array proteomics detects increased MMP-8 in CSF after spinal cord injury. J Neuroinflamm. 2012;9:122.","journal-title":"J Neuroinflamm"},{"key":"70_CR27","first-page":"3419","volume":"11","author":"W Beuche","year":"2000","unstructured":"Beuche W, Yushchenko M, M\u00e4der M, Maliszewska M, Felgenhauer K, Weber F. Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis. Neuro Rep. 2000;11:3419\u201322.","journal-title":"Neuro Rep"},{"key":"70_CR28","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1161\/01.STR.0000127420.10990.76","volume":"35","author":"JC Adair","year":"2004","unstructured":"Adair JC, Charlie J, Dencoff JE, Kaye JA, Quinn JF, Camicioli RM, Stetler-Stevenson WG, Rosenberg GA. Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease. Stroke. 2004;35:e159\u201362.","journal-title":"Stroke"},{"key":"70_CR29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/alzrt44","volume":"2","author":"E Stomrud","year":"2010","unstructured":"Stomrud E, Bj\u00f6rkqvist M, Janciauskiene S, Minthon L, Hansson O. Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer\u2019s disease. Alzheimers Res Ther. 2010;2:20.","journal-title":"Alzheimers Res Ther"},{"key":"70_CR30","doi-asserted-by":"crossref","first-page":"e32218","DOI":"10.1371\/journal.pone.0032218","volume":"7","author":"TC Lund","year":"2012","unstructured":"Lund TC, Stadem PS, Panoskaltsis-Mortari A, Raymond G, Miller WP, Tolar J, Orchard PJ. Elevated cerebral spinal fluid cytokine levels in boys with cerebral adrenoleukodystrophy correlates with MRI severity. PLoS ONE. 2012;7:e32218.","journal-title":"PLoS ONE"},{"key":"70_CR31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3233\/JAD-131634","volume":"40","author":"B Mroczko","year":"2014","unstructured":"Mroczko B, Groblewska M, Zboch M, Kulczy\u0144ska A, Koper OM, Szmitkowski M, Kornhuber J, Lewczuk P. Concentrations of matrix metalloproteinases and their tissue inhibitors in the cerebrospinal fluid of patients with Alzheimer\u2019s disease. J Alzheimers Dis. 2014;40:351\u20137.","journal-title":"J Alzheimers Dis"},{"key":"70_CR32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1750-1326-6-69","volume":"6","author":"H Jiang","year":"2011","unstructured":"Jiang H, Hampel H, Prvulovic D, Wallin A, Blennow K, Li R, Shen Y. Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer\u2019s disease. Mol Neurodegener. 2011;6:69.","journal-title":"Mol Neurodegener"},{"issue":"8","key":"70_CR33","first-page":"2693","volume":"37","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Fan F, Zeng G, Zhou L, Zhang J, Jiao H, Zhang T, Su D, Yang C, Wang X, Xiao K, Li H, Zhong Z. Temporal analysis of blood-brain barrier disruption and cerebrospinal fluid matrix metalloproteinases in rhesus monkeys subjected to transient ischemic stroke. J Cereb Blood Flow Metab. 2016;37(8):2693\u2013974.","journal-title":"J Cereb Blood Flow Metab."},{"key":"70_CR34","first-page":"80","volume":"10","author":"YJ Li","year":"2013","unstructured":"Li YJ, Wang ZH, Zhang B, Zhe X, Wang MJ, Shi ST, Bai J, Lin T, Guo CJ, Zhang SJ, Kong XL, Zuo X, Zhao H. Disruption of the blood-brain barrier after generalized tonic-clonic seizures correlates with cerebrospinal fluid MMP-9 levels. J Neuroinflamm. 2013;10:80.","journal-title":"J Neuroinflamm"},{"key":"70_CR35","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/(SICI)1097-0142(19980301)82:5<923::AID-CNCR18>3.0.CO;2-2","volume":"82","author":"MH Friedberg","year":"1998","unstructured":"Friedberg MH, Glantz MJ, Klempner MS, Cole BF, Perides G. Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis. Cancer. 1998;82:923\u201330.","journal-title":"Cancer"},{"key":"70_CR36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11060-014-1707-8","volume":"122","author":"MY Si","year":"2015","unstructured":"Si MY, Fan ZC, Li YZ, Chang XL, Xie QD, Jiao XY. The prognostic significance of serum and cerebrospinal fluid MMP-9, CCL2 and sVCAM-1 in leukemia CNS metastasis. J Neurooncol. 2015;122:229\u201344.","journal-title":"J Neurooncol"},{"key":"70_CR37","doi-asserted-by":"crossref","first-page":"12766","DOI":"10.1523\/JNEUROSCI.0006-15.2015","volume":"35","author":"M Brkic","year":"2015","unstructured":"Brkic M, Balusu S, Van Wonterghem E, Gorl\u00e9 N, Benilova I, Kremer A, Van Hove I, Moons L, De Strooper B, Kanazir S, Libert C, Vandenbroucke RE. Amyloid \u03b2 oligomers disrupt blood-CSF barrier integrity by activating matrix metalloproteinases. J Neurosci. 2015;35:12766\u201378.","journal-title":"J Neurosci"},{"key":"70_CR38","doi-asserted-by":"crossref","first-page":"e20599","DOI":"10.1371\/journal.pone.0020599","volume":"6","author":"S Feng","year":"2011","unstructured":"Feng S, Cen J, Huang Y, Shen H, Yao L, Wang Y, Chen Z. Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins. PLoS ONE. 2011;6:e20599.","journal-title":"PLoS ONE"},{"key":"70_CR39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-6850-3_18","volume":"1574","author":"C Conrad","year":"2017","unstructured":"Conrad C, Miller MA, Bartsch JW, Schlomann U, Lauffenburger DA. Simultaneous detection of metalloprotease activities in complex biological samples using the PrAMA (Proteolytic Activity Matrix Assay) method. Methods Mol Biol. 2017;1574:243\u201353.","journal-title":"Methods Mol Biol"},{"key":"70_CR40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1468-1331.1994.tb00051.x","volume":"1","author":"L Paemen","year":"1994","unstructured":"Paemen L, Olsson T, S\u00f6derstr\u00f6m M, van Damme J, Opdenakker G. Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases. Eur J Neurol. 1994;1:55\u201363.","journal-title":"Eur J Neurol"},{"key":"70_CR41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12974-017-0801-1","volume":"14","author":"CW Ong","year":"2017","unstructured":"Ong CW, Pabisiak PJ, Brilha S, Singh P, Roncaroli F, Elkington PT, Friedland JS. Complex regulation of neutrophil-derived MMP-9 secretion in central nervous system tuberculosis. J Neuroinflamm. 2017;14:31.","journal-title":"J Neuroinflamm"},{"key":"70_CR42","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1074\/mcp.M114.041533","volume":"14","author":"B Dislich","year":"2015","unstructured":"Dislich B, Wohlrab F, Bachhuber T, M\u00fcller SA, Kuhn PH, Hogl S, Meyer-Luehmann M, Lichtenthaler SF. Label-free quantitative proteomics of mouse Cerebrospinal fluid detects \u03b2-Site APP cleaving enzyme (BACE1) protease substrates in vivo. Mol Cell Proteom. 2015;14:2550\u201363.","journal-title":"Mol Cell Proteom"},{"key":"70_CR43","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1021\/ja307866z","volume":"135","author":"CH Chen","year":"2013","unstructured":"Chen CH, Miller MA, Sarkar A, Beste MT, Isaacson KB, Lauffenburger DA, Griffith LG, Han J. Multiplexed protease activity assay for low-volume clinical samples using droplet-based microfluidics and its application to endometriosis. J Am Chem Soc. 2013;135:1645\u20138.","journal-title":"J Am Chem Soc"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-017-0070-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T07:22:46Z","timestamp":1570000966000},"score":1,"resource":{"primary":{"URL":"http:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-017-0070-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,14]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["70"],"URL":"https:\/\/doi.org\/10.1186\/s12987-017-0070-5","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,14]]},"article-number":"22"}}